ClinicalTrials.gg
Drug

Izalontamab clinical trials

Also written SI-B001.

studies test it
10
open now
0
in phase 3
2
first study started
2020

How each study uses izalontamab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

SI-B001
10

Studies by the year they started

10 studies that test it; most in 2021 (4)

Studies that test izalontamab, by start year
YearStudies
20201
20214
20221
20233
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
8
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 0

Sichuan Baili Pharmaceutical Co., Ltd. (10)

Often tested with

Tested in the same studies.

Danvilostomig (2) · Docetaxel (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test izalontamab.

Studies

Open first, then newest update. How each study uses izalontamab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Given beside what is tested · 1 — izalontamab is usual care or a partner of the new treatment

Codes

What other systems call izalontamab · ClinicalTrials.gg INT017877

  • UNII (FDA) S8YH2C9NLAIZALONTAMABOne source FDA
  • NCI Thesaurus C178396IzalontamabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.